Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

  • There is currently no data for TM17

Director/PDMR Shareholding

31 Mar 2023 11:15

RNS Number : 9630U
Team17 Group PLC
31 March 2023
 

31 March 2023

 

Team17 Group plc

("Team17" or the "Company")

 

Director / PDMR Shareholding

 

Team17, a global games label, creative partner, developer, and publisher of independent ("indie") premium video games, educational entertainment apps for children and working simulation games, announces that it has received notification from Mark Crawford, Chief Financial Officer, that on 31 March 2023 he purchased 6,622 ordinary shares of £0.01 each in the Company ("Ordinary Shares") at a price of 377.5 pence per Ordinary Share.

 

Following this purchase, Mr Crawford holds 23,137 Ordinary Shares, representing approximately 0.02 per cent. of the issued Ordinary Shares.

 

As at the date of this announcement, the Company has 145,593,271 Ordinary Shares in issue.

 

Enquiries

 

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Mark Crawford, Chief Financial Officer

 

via Vigo Consulting

 

Houlihan Lokey UK Limited (Nominated Adviser)

Adrian Reed / Tim Richardson

 

+44 (0)161 250 3577

Berenberg (Broker)

Chris Bowman / Toby Flaux / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Fiona Hetherington / Kate Kilgallen

team17@vigoconsulting.com

+44 (0)20 7390 0233

 

 

About Team17

Team17 Group plc is a global provider of games entertainment to a broad audience. The Group now includes a games entertainment label and creative partner for indie developers, a leading developer of educational apps, targeting children under the age of eight and a leading working simulation games developer and publisher.

Visit www.team17.com for more info.

The Company publicly discloses the following notifications pursuant to the EU Market Abuse Regulations:

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Mark Crawford

 

2

 

Reason for the notification

 

a)

 

Position/status

  

Chief Financial Officer and PDMR

 

b)

 

Initial notification /Amendment

Initial notifications

 

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Team17 Group plc

b)

LEI

 

2138006EUUCCL4ZI5E51

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of £0.01 each ("Ordinary Shares")

 

 

GB00BYVX2X20

 

b)

 

Nature of the transaction

Acquisition of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

 

377.5 pence

 

 

6,622

 

 

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

Acquisition of 6,622 Ordinary Shares at 377.5 pence per Ordinary Share

e)

 

Date of the transaction

31 March 2023

f)

 

Place of the transaction

AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKDBDKBKDQNN
Date   Source Headline
23rd Jan 20257:00 amRNSTrading Update and Change of Company Name
15th Nov 202412:30 pmRNSIssue of Shares and Total Voting Rights
15th Nov 202410:00 amRNSEstablishment of New Option Plan, Grant of Options
7th Nov 20243:33 pmRNSDirector Dealing
6th Nov 20247:00 amRNSChange of Nomad & Directors Disclosures
1st Nov 20247:00 amRNSHoldings in Company
30th Oct 20247:00 amRNSBoard Change
24th Oct 20244:20 pmRNSHoldings in Company
14th Oct 20247:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSChange of Nominated Advisor
17th Sep 20247:00 amRNSHalf Year Results
11th Sep 20243:02 pmRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSHoldings in Company
4th Sep 20242:25 pmRNSHoldings in Company
28th Aug 20247:00 amRNSNotice of Results & Analyst/Investor Presentations
22nd Aug 20247:00 amRNSHoldings in Company
14th Aug 20244:15 pmRNSDirector/PDMR Shareholding
17th Jul 20247:00 amRNSTrading Update
11th Jul 20245:03 pmRNSDirector/PDMR Shareholding
9th Jul 20244:18 pmRNSDirector/PDMR Shareholding
19th Jun 202411:15 amRNSResult of AGM
13th Jun 20249:20 amRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSAppointment of Joint Corporate Broker
23rd May 202412:00 pmRNSPosting of Annual Report and Notice of AGM
13th May 20244:55 pmRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSUnaudited Final Results 2023
12th Apr 20241:16 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSNotice of Analyst & Investor Meetings, FY Results
19th Mar 20243:29 pmRNSHoldings in Company
13th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 20248:58 amRNSNotice of Results
14th Feb 20241:00 pmRNSDirector/PDMR Shareholding
13th Feb 20244:28 pmRNSDirector/PDMR Shareholding
1st Feb 20241:10 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading Update
19th Jan 20243:01 pmRNSHolding(s) in Company
12th Jan 20244:53 pmRNSHolding(s) in Company
12th Jan 20243:04 pmRNSHolding(s) in Company
11th Jan 20243:23 pmRNSDirector/PDMR Shareholding
14th Dec 20239:15 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSDirector Dealings
27th Nov 20237:00 amRNSDirector Dealings
24th Nov 20237:00 amRNSTrading Update
15th Nov 20233:29 pmRNSHolding(s) in Company
13th Nov 20234:57 pmRNSDirector/PDMR Shareholding
30th Oct 20233:51 pmRNSHolding(s) in Company
18th Oct 202312:41 pmRNSHolding(s) in Company
11th Oct 20235:14 pmRNSDirector/PDMR Shareholding
21st Sep 20231:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.